Norepinephrine Uptake Inhibitors

Norepinephrine Reuptake Inhibitor

Cytochrome P450 2D6 Inhibitors

Cytochrome P450 1A2 Inhibitors

Cytochrome P450 2B6 Inhibitors

Cytochrome P450 3A4 Inhibitors

Depression

<section class="Section" data-sectioncode="34089-3"><a name="S11"></a><a name="section-10"></a><p></p><h1>11 DESCRIPTION</h1><p class="First">Qelbree contains viloxazine, a selective norepinephrine reuptake inhibitor, in the form of viloxazine hydrochloride which is (±)-2-[(2-ethoxyphenoxy)methyl]morpholine hydrochloride.  The molecular formula is C          <span class="Sub">13</span>H          <span class="Sub">20</span>NO          <span class="Sub">3</span>Cl and its molecular weight is 273.8 (HCl salt) with the following structural formula:        </p><p><img alt="Chemical Structure" src="qelbree-01.jpg"/></p><p>Viloxazine hydrochloride is a white to off-white powder. Viloxazine hydrochloride is soluble in water, 0.1N HCl and aqueous solutions of pH 9.5 and lower. Viloxazine hydrochloride is sparingly soluble in methanol, very slightly soluble in acetonitrile, acetic acid and isopropyl alcohol, and practically insoluble in ethyl acetate.</p><p>Qelbree extended-release capsules are intended for oral administration. Each extended-release capsule contains 100 mg, 150 mg, and 200 mg of viloxazine free base equivalent to 115mg, 173mg, and 231mg, respectively, of viloxazine hydrochloride salt.</p><p>The inactive ingredients are: Ammonium hydroxide, black iron oxide, butyl alcohol, corn starch, ethylcellulose, FD&amp;C Blue #1, FD&amp;C Red #28, FD&amp;C Yellow #5, FD&amp;C Yellow #6, FD&amp;C Yellow #10, gelatin, hypromellose, isopropyl alcohol, lactose monohydrate, medium chain triglycerides, oleic acid, polyethylene glycol, potassium hydroxide, propylene glycol, shellac, strong ammonia solution, sucrose, talc, triacetin, titanium dioxide.</p></section>

QELBREE

viloxazine

24 HR viloxazine 100 MG Extended Release Oral Capsule

Qelbree

24 HR viloxazine 100 MG Extended Release Oral Capsule [Qelbree]

24 HR viloxazine 150 MG Extended Release Oral Capsule

24 HR viloxazine 150 MG Extended Release Oral Capsule [Qelbree]

24 HR viloxazine 200 MG Extended Release Oral Capsule

24 HR viloxazine 200 MG Extended Release Oral Capsule [Qelbree]

Psoriasis (PsO)

Psoriatic Arthritis (PsA)

Ankylosing Spondylitis (AS)

Nonradiographic Axial Spondyloarthritis

Taltz

Juvenile Idiopathic Arthritis

Hidradenitis Suppurativa (HS)

Cosentyx

Siliq

Tremfya

Crohn's Disease (CD)

Ulcerative Colitis (UC)

Stelara

Skyrizi

Ilumya

Migraine

Cluster Headache

Migraine Prevention

Emgality

Qulipta

Acute Migraine

Ubrelvy

Nurtec ODT

Vyepti

Aimovig

Ajovy

Breast Cancer: HR+ (HER2-)

Verzenio

Ibrance

Kisqali

Atopic Dermatitis (Eczema)

Cibinqo

Eucrisa

Asthma (injectable)

Asthma OCS Dependent

Nasal Polyposis

Eosinophilic Esophagitis (EoE)

Prurigo Nodularis

Dupixent

Opzelura

Adbry

NSCLC ALK+ OR ROS1+ Disease

Lorbrena

Alecensa

Alunbrig

NSCLC cMET Mutation

Xalkori

Rheumatoid Arthritis (RA)

Xeljanz

Uveitis

Graft Versus Host Disease (GVHD)

Orencia

COVID-19 Treatment

Alopecia Areata

Olumiant

Multiple Sclerosis (MS)

Secondary Progressive Multiple Sclerosis

Zeposia

Rinvoq

Entyvio

Report Adverse Event

Prescribing Information

Medication Guide 

Pharmacy List 

Online Sample Form 

Coverage Authorization Request 

Coverage Authorization Appeals 

Enroll in Patient Savings Program 

About Qelbree: Adults 

Starting Qelbree: Pediatrics 

Patient Stories: Pediatrics 

FAQs: ADHD (Pediatrics)

Starting Qelbree: Adults 

Patient Stories: Adults 

Doctor Discussion Guide: Adults 

FAQs: Adults 

Instructions For Use: ADHD (Children)

Instructions For Use: ADHD (Adults)